1 active not recruiting, 1 completed, 1 suspended. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Suspended 1 |
Follow Small Intestinal Adenocarcinoma: new trials by email Literature Review of Small Intestinal Adenocarcinoma trials Research Report on Small Intestinal Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE - Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma | Phase 2 | Suspended | Thomas Jefferson University | 48 | 2020-11-10 | 2026-09-14 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma Bevacizumab, Capecitabine, Oxaliplatin - Ampulla of Vater Adenocarcinoma, Small Intestinal Adenocarcinoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 30 | 2011-05-06 | 2020-09-03 |
Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenocarcinoma, Mucinous (1) · Adrenocortical Carcinoma (1) · Bile Duct Neoplasms (1) · Carcinoma, Acinar Cell (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Basal Cell (1) · Carcinoma, Endometrioid (1) · Carcinoma, Giant Cell (1) · Carcinoma, Transitional Cell (1) · Carcinosarcoma (1) · Cholangiocarcinoma (1) · Chordoma (1) · Colorectal Neoplasms (1) · Cystadenocarcinoma, Mucinous (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Pancreatic Diseases (2) · Adenocarcinoma (1) · Adenocarcinoma of Lung (1) · Adnexal Diseases (1) · Adrenal Cortex Diseases (1) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1)
Bevacizumab (1) · CTLA-4 Antigen (1) · Capecitabine (1) · Disulfides (1) · Immunoglobulin G (1) · Ipilimumab (1) · Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · Oxaliplatin (1) · Specimen Handling (1)
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Thomas Jefferson University (1)
United States (3) · Guam (1)
Babar Bashir, MD (1) · Michael Overman (1) · Sandip P Patel (1)
PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
P30CA016672 (1), U10CA180888 (1)